Muscle cachexia: Current concepts of intracellular mechanisms and molecular regulation

Annals of Surgery

Volumn 233, Issue 1, 2001, Pages 9-17

  Hasselgren, Per Olof ^a   Fischer, Josef E ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BORONIC ACID DERIVATIVE; BORTEZOMIB; CALCIUM; CALPAIN; COUMARIN DERIVATIVE; LACTACYSTIN; LIGASE; MUSCLE PROTEIN; PROTEASOME; PROTEASOME INHIBITOR; SULFONE; TRANSCRIPTION FACTOR; UBIQUITIN; UBIQUITIN CONJUGATING ENZYME;

CACHEXIA; CANCER; CATABOLISM; GENE EXPRESSION; HUMAN; INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SEPSIS; SKELETAL MUSCLE;

CACHEXIA; CALCIUM; CALPAIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MULTIENZYME COMPLEXES; MUSCLE, SKELETAL; NEOPLASMS; SEPSIS; SIGNAL TRANSDUCTION; UBIQUITINS; WOUNDS AND INJURIES;

EID: 0035164533     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200101000-00003     Document Type: Review

References (68)

1. Exchange of amino acids by muscle and liver in sepsis. Comparative studies in vivo and in vitro
2. Respiratory fuels and nitrogen metabolism in vivo in small intestine of fed rats
3. Properties of glutamine release from muscle and its importance for the immune system
4. Respiratory muscle injury in animal models and humans
5. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?
6. The immediate cause of death in cancer
7. Total and myofibrillar protein breakdown in different types of rat skeletal muscle effects of sepsis and regulation by insulin
8. Urinary excretion of 3-methylhistidine: An assessment of muscle protein catabolism in adult normal subjects and during malnutrition, sepsis and skeletal trauma
9. 2+-dependent systems
10. Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle
11. Energy-ubiquitin dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids
12. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle
13. Burn injury stimulates multiple proteolytic pathways in skeletal muscle including the ubiquitin-energy-dependent pathway
14. The molecular regulation of protein breakdown following burn injury is different in fast-and slow-twitch skeletal muscle
15. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine-triphosphate dependent pathway involving ubiquitin and proteasomes
16. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatonia
17. The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer
18. The ubiquitin-proteasome pathway. Review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions
19. Role of the ubiquitin-proteasome pathway in sepsis-induced muscle catabolism
20. Pathways of muscle protein breakdown in injury and sepsis
21. Molecular biology of proteasomes
22. From the cradle to the grave: Ring complexes in the life of a protein
23. The 26S proteasome
24. Lessons from the discovery of the ubiquitin system
25. 14 kDa ubiquitin-conjugating enzyme: Structure of the rat gene and regulation upon fasting and by insulin
26. Insulin-like growth factor I stimulates degradation of an mRNA transcript encoding the 14 kDa ubiquitin-conjugating enzyme
27. The mouse and human genes encoding the recognition component of the N-end rule pathway
28. 14k mRNA in skeletal muscle
29. The gene expression of ubiquitin ligase E3α is upregulated in skeletal muscle during sepsis in rats. Potential role of glucocorticoids
30. Rates of ubiquitin cojugation increase when muscles atrophy, largely through activation of the N-end rule pathway
31. The deubiquitinating enzymes
32. The N-end rule pathway of protein degradation
33. The ubiquitin-proteasome proteolytic pathway
34. The N-end rule pathway catalyzes a major fraction of the protein degradation in skeletal muscle
35. Purification and characterization of a novel species of ubiquitin-carrier protein, E2, that is involved in degradation of non-"N-end rule" protein substrates
36. Isolation, characterization, and partial purification of a novel ubiquitin-protein ligase, E3. Targeting of protein substrates via multiple and distinct recognition signals and conjugating enzymes
37. Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown
38. Activity and expression of 20S proteasome are increased in skeletal muscle during sepsis
39. The sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors
40. Burn injury upregulate the activity and gene expression of the 20S proteasome in rat skeletal muscle
41. Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle
42. Proteasome inhibitors: Valuable new tools for cell biologists
43. Proteasome blockers inhibit protein breakdown in skeletal muscle after burn injury in rats
44. Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles
45. Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart
46. Proteasome inhibitors: A novel class of potent and effective antitumor agents
47. Sepsis-induced muscle proteolysis is prevented by a proteasome inhibitor in vivo
48. Increased mRNA levels for components of the lysosomal, calcium-activated and ATP ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients
49. No alteration in gene expression of components of the ubiquitin-proteasome proteolytic pathway in dystrophin-deficient muscle
50. Glucocorticoids do not regulate the expression of proteolytic genes in skeletal muscle from Cushing syndrome patients
51. Ubiquitin and proteasome gene expression is increased in skeletal muscle of slim AIDS patients
52. Ubiquitin changes in human biceps muscles following exercise-induced damage
53. Ovine skeletal muscle multicatalytic proteinase complex (proteasome): Purification, characterization and comparison of its effects on myofibrils with μ-calpams
54. Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts
55. Architecture and function in the muscle sarcomere
56. Sepsis stimulates release of myofilaments in skeletal muscle by a calcium-dependent mechanism
57. Calcium antagonists decrease plasma and tissue concentrations of tumor necrosis factor-α, interleukin-1B, and interleukin-1α in a mouse model of endotoxin
58. The ubiquitin system
59. Easily releasable myofilaments from skeletal and cardiac muscles maintained in vitro. Role in myofibrillar assembly and turnover
60. Glutahione regulation of tumor necrosis factor α-induced NF-κB activation in skeletal muscle-derived L6 cells
61. The amount of the glucocorticoid receptor (GR) and its hormone binding activity are increased in skeletal muscle during sepsis
62. Sepsis upregulates the DNA binding activity of the inflammatory transcription factors NF-κB, C/EBP and AP-1 in rat skeletal muscle
63. Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis
64. Reduced muscle protein breakdown in septic rats following treatment with interleukin-1 receptor antagonist
65. Induction of muscle protein degradation by a tumour factor
66. Tumor necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms
67. Coordinate regulation of glucocorticoid receptor and c-jun mRNA levles: Evidence for cross-talk between two signaling pathways at the transcriptional level
68. Signaling pathways regulating protein turnover in skeletal muscle